Literature DB >> 12109673

Liver transplantation for fulminant hepatitis at Stanford University.

Amy Lu1, Humberto Monge, Kenneth Drazan, Maria Millan, Carlos O Esquivel.   

Abstract

BACKGROUND: To review the clinical characteristics and outcomes of 26 patients evaluated for liver transplantation for fulminant hepatic failure at Stanford University and Lucile Packard Children's Hospital in an attempt to identify risk factors and prognostic predictors of survival.
METHODS: A retrospective review of the records of 26 consecutive patients who were evaluated for possible liver transplantation for acute liver failure from May 1, 1995, to January 1, 2000. Pretransplant patient demographics and clinical characteristics were collected, and the data were analyzed by univariate and multivariate analysis.
RESULTS: Clinical assessment of encephalopathy did not predict outcome. Patients with abnormal computed tomography (CT) of the brain had a twofold increase in mortality compared with those patients with normal studies (p = 0.03). Patients requiring mechanical ventilation and continuous venovenous hemofiltration (CVVH) also had a poor prognosis.
CONCLUSION: Predictors of poor outcome after fulminant hepatic failure include abnormal CT scan, mechanical ventilation, and requirement for hemofiltration.

Entities:  

Mesh:

Year:  2002        PMID: 12109673     DOI: 10.1007/bf02990106

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  28 in total

1.  Fulminant hepatic failure.

Authors:  G J Russell; J F Fitzgerald; J H Clark
Journal:  J Pediatr       Date:  1987-09       Impact factor: 4.406

2.  Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients.

Authors:  D J Ritt; G Whelan; D J Werner; E H Eigenbrodt; S Schenker; B Combes
Journal:  Medicine (Baltimore)       Date:  1969-03       Impact factor: 1.889

Review 3.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

4.  When should a decision to proceed with transplantation actually be made in cases of fulminant or subfulminant hepatic failure: at admission to hospital or when a donor organ is made available?

Authors:  D H Van Thiel
Journal:  J Hepatol       Date:  1993-01       Impact factor: 25.083

5.  Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure.

Authors:  P M Harrison; J G O'Grady; R T Keays; G J Alexander; R Williams
Journal:  BMJ       Date:  1990-10-27

6.  Transplantation of the liver in adults and children with fulminant hepatic failure.

Authors:  C Vickers; J Neuberger; J Buckels; P McMaster; E Elias
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

7.  Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure.

Authors:  S Izumi; P G Langley; J Wendon; A J Ellis; R B Pernambuco; R D Hughes; R Williams
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

8.  Predicting survival in fulminant hepatic failure using serum Gc protein concentrations.

Authors:  W M Lee; R M Galbraith; G H Watt; R D Hughes; D D McIntire; B J Hoffman; R Williams
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

9.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

10.  Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.

Authors:  L M Pereira; P G Langley; K M Hayllar; J M Tredger; R Williams
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

View more
  1 in total

1.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.